[{"AccountsPayableCurrent_0_Q2_USD":5502000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-37000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":23000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":0.93,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":32587000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":30735000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":5000.0,"OtherLiabilitiesCurrent_0_Q2_USD":610000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":7161000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3309000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6762000.0,"DisposalGroupIncludingDiscontinuedOperationOperatingExpense_1_Q2_USD":27000.0,"DividendsPayableCurrentAndNoncurrent_0_Q2_USD":0.0,"DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_Q2_USD":285000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":316000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":1897671.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":734800.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":316000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":-463000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":87000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":659000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-11629000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-27102000.0,"DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_2_Q2_USD":1000.0,"DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_1_Q2_USD":-27000.0,"DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_2_Q2_USD":-285000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-11570000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-26898000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-32000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":81000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1182000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":19.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":557222.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2489000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_Q2_USD":-285000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"FinanceLeasePrincipalPayments_2_Q2_USD":92000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":435000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":37000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_1_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_2_Q2_USD":-0.01,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":7380000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":2289000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"OperatingLeaseLiability_0_Q2_USD":3820000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":567000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3253000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":5000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":58000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":27139000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q2_USD":-27000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_0_Q2_USD":2253000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":10913000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3279799.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.9,"OtherLiabilitiesNoncurrent_0_Q2_USD":3331000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":79000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3309000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":28000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":1000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":35501000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":35528000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":35528000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":3435000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":68115000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-3350000.0,"DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_0_Q2_USD":36000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0_Q2_USD":8604000.0,"OtherAssetsNoncurrent_0_Q2_USD":4653000.0,"LongTermDebt_0_Q2_USD":10573000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":75000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-890000.0,"Liabilities_0_Q2_USD":35633000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":84999000.0,"LiabilitiesCurrent_0_Q2_USD":17745000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":10821000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":3455000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-17626000.0,"NetIncomeLoss_1_Q2_USD":-11597000.0,"NetIncomeLoss_2_Q2_USD":-27183000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":141000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2065000.0,"ProfitLoss_2_Q2_USD":-27183000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2230000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-480710000.0,"StockholdersEquity_0_Q2_USD":49366000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-4895000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":42133646.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-6026000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5572000.0,"AccountsReceivableNetCurrent_0_Q2_USD":775000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":15000.0,"AdditionalPaidInCapital_0_Q2_USD":530061000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6268451.0,"Assets_0_Q2_USD":84999000.0,"AssetsCurrent_0_Q2_USD":70955000.0,"CommonStockSharesIssued_0_Q2_shares":42691114.0,"CommonStockSharesOutstanding_0_Q2_shares":42691114.0,"CommonStockValue_0_Q2_USD":null,"CostOfRevenue_1_Q2_USD":1389000.0,"CostOfRevenue_2_Q2_USD":2658000.0,"Depreciation_1_Q2_USD":297000.0,"Depreciation_2_Q2_USD":595000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.28,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.65,"GeneralAndAdministrativeExpense_2_Q2_USD":11773000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":41876037.0,"AccruedLiabilitiesCurrent_0_Q2_USD":9344000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":751000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":532000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-189000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-11000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":21.33,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3279799.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.9,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.3,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":1767000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":339000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":8195000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":195000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":75000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":75000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":75000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":0.956,"AccruedProfessionalFeesCurrent_0_Q2_USD":112000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4891000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":549000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":219000.0,"OperatingIncomeLoss_2_Q2_USD":-26887000.0,"OperatingIncomeLoss_1_Q2_USD":-11381000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2046000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6466000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15909000.0,"ShareBasedCompensation_2_Q2_USD":6762000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.8519,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0087,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2661000.0,"PreferredStockValue_0_Q2_USD":null,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":3453000.0,"Ticker":"ACRS","CIK":"1557746","name":"ACLARIS THERAPEUTICS, INC.","OfficialName":"Aclaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1075670582.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]